Neurotransmitter glutamate: its clinical importance.
Excitatory amino acid glutamate has several important functions in the mammalian central nervous system (CNS). This review focuses on the transmitter role of glutamate and discusses anatomical and pharmacological data of clinical neurological relevance. Experimental and clinical conditions which have been associated with altered content, uptake, membrane binding or release of glutamate in the CNS are discussed. Such conditions include, epilepsy, disorders of the basal ganglia, cerebral ischemia, hypoxia, hypoglycemia, metabolic encephalopathies, olivopontocerebellar atrophy and cerebellar ataxias, amino acidopathies, mental and other neurological disorders. With the exception of a few fibre systems, it is very difficult to differentiate between glutamate and aspartate as CNS transmitters. The term glutamate is, thus, used in the sense glutamate and/or aspartate unless specifically stated.
D000818:Animals; D005971:Glutamates / Q000502:physiology*; D018698:Glutamic Acid; D006801:Humans; D051379:Mice; D009420:Nervous System / Q000503:physiopathology*; D009422:Nervous System Diseases / Q000503:physiopathology*; D051381:Rats; D009435:Synaptic Transmission
D005971:Glutamates; D018698:Glutamic Acid